Publications - publikationer  (updated October 2009)

Section 1    no 1-12        Monographs
 Section 2    no 13-153   Scientific publications,
Section 3    no 1-8          Ongoing studies 
Section 4    link to          Other written material (instructions, guidelines, comments etc)
Section 5    link to          Climate change blog (www.videnskab.dk)
References in each section listed according to year of publication

  1. 1. Monographs

  2. Lidegaard Ø. Oral contraceptives and cerebral thromboembolism. An epidemiological approach. Dissertation. Copenhagen, October 1996.

  3. Lidegaard Ø. Prize essay: 1. prize at the prize essay called by The Medical Association of Copenhagen. Title: "The role of doctors year 2000". Published 1986: "The future of health care" [da] in "The role of doctors, with special reference to Denmark", p 9-24, Lægeforeningens Forlag, Copenhagen 1986.

  4. Steensen JP, Andreasen PB, Lidegaard Ø (ed). Scientific methods for quality assurance in health care sector. [da] Danish Research Council, committee for primary health research and technology assessment and Danish Hospital Institute, November 1988.

  5. Lidegaard Ø. Report: "New educational technologies - a contribution for a solution of educational problems in health sector". [da] Danish Hospital Institute, DSI-Rapport 89.01, Copenhagen 1989.

  6. Lidegaard Ø, Weber T. Prize essay: 1. prize at the prize essay called by "Society of Young Gynaecologists". Title: "Gynaecology and obstetrics in Denmark year 2000". March 1990. Published by the Society October 1990.

  7. Lidegaard Ø, McNair P, Dirksen A (ed): Medical informatics in Denmark/Europe. [da] DSI-rapport 90.08, Copenhagen 1990.

  8. Lidegaard Ø, Looms P. Interactive media for teaching. CD-ROM, Laservision and interactive video. [da]. Directory of Copenhagen Hospitals, 1990.

  9. Lidegaard Ø, Steensen JP. Prize essay called by "Lundbeckfonden". Title: "Structure and financing of the Danish Health Care System in the nineties". [da] Published May 1992, Jurist og Økonomforbundets Forlag, 1992.

  10. Lidegaard Ø. "Women in menopause" [Da] . Kvinder i overgangsalderen. Danmarks Radio. ”Lægens bord”. DR-multimedie, november 2001.

  11. Lidegaard Ø. "Infertility. New knowledge - new options [Da]. Barnløshed. Nu viden – nye muligheder.  Danmarks Radio. ”Lægens bord”. DR-multimedie, oktober 2002.

  12. Lidegaard Ø, Hammerum M. "National Register of Patients as a tool of assessing clinical quality at Gynaecological departments [Da]. Landspatientregisteret til kvalitetssikring i det gynækologiske speciale. Sundhedsstyrelsen 2002. Pdf

2. Scientific publications (sorted after year of publication)

  1. Lidegaard Ø. Thrombo-embolic insults in the central nervous system and oral contraceptives. [Da]. Ugeskr Læger 1982; 144: 2769-72.

  2. Lidegaard Ø, Gyldensted C, Zeeberg I, Juhler M. Computer tomographic findings in acute multiple sclerosis. Acta Neurol Scand 1983; 68: 77-83.

  3. Lidegaard Ø, Boas J, Philip P. Primary affection of central nervous system at acute leukaemia. [da]. Ugeskr Læger 1983; 145: 3580-1.

  4. Lidegaard Ø, Jansen EC, Larsen TK. The influence of propranolol on the postural stability. Acta Neurol Scand 1984; 69: 412-16.

  5. Lidegaard Ø. Smoking habits among 15-44 year old women in 1983. [da]. Ugeskr Laeger 1984; 146: 3058-60.

  6. Lidegaard Ø. Use of oral contraceptives in 1983. [da]. Ugeskr Læger 1984; 146: 1172-4.

  7. Lidegaard Ø, Søe M, Andersen MVN. Cerebral thromboembolism among young women and men in Denmark 1977- 1982. Stroke 1986; 17: 670-5.

  8. Overgaard K, Hauch O, Lidegaard Ø. Deep venous thromboembolism and oral contraceptives. [da]. Ugeskr Laeger 1986; 148: 2348-50.

  9. Lidegaard Ø, Andersen MVN, Søe M. Cerebral thromboembolism, oral contraceptives and pregnancy. [da]. Ugeskr Laeger 1987; 149: 2135-7.

  10. Lidegaard Ø. Cerebrovascular deaths before and after the appearance of oral contraceptives. Acta Neurol Scand 1987; 75: 427-33.

  11. Lidegaard Ø, Overgaard K, Hauch O. The oral contraceptive user. Acta Obstet Gynecol Scand 1988; 67: 27-31.

  12. Lidegaard Ø. The future health care system. [da]. Månedsskr Prakt Laegegern 1988; 66: 7-15.

  13. Lidegaard Ø, Helm P. Sexual and reproductive life events in relation to duration of oral contraceptive use. Contraception 1988; 38: 69-77.

  14. Lidegaard Ø, Andreasen PB, Steensen JP. Quality assessment in health care system. [da]. Ugeskr Laeger 1989; 151: 924-7.

  15. Lidegaard Ø. New information technologies for teaching - also in the Danish health care sector? [da]. Ugeskr Læger 1989; 151: 1399-1402.

  16. Lidegaard Ø, Helm P, Kreiner S. Methods at research of sexual and contraceptive habits among 15-44 old women. [da]. Nord Sexol 1989; 7: 243-54.

  17. Lidegaard Ø. New information technologies for teaching - also in the Danish health care sector? [da]. Tidsskr for danske sygehuse 1989; 6: 195-9.

  18. Trap R, Helm P, Lidegaard Ø. Helm E. Premature rupture of the fetal membranes, the phases of the moon and barometer readings. Gynecol Obstet Invest 1989; 28: 14-8.

  19. Lidegaard Ø, Helm P. Sexual habits among 15-44 old women. [da]. Nord Sexol 1990; 8: 124-36.

  20. Lidegaard Ø, Helm P. Reproductive parameters and contraceptive habits among 15-54 year old women. [da]. Nord Sexol 1990; 8: 282-91.

  21. Lidegaard Ø, Danielsen O. New teaching technologies in primary health sector. [da]. Månedsskr Prakt Laegegern 1990; 68: 25-30.

  22. Lidegaard Ø, Helm P. Pelvic inflammatory disease: The influence of sexual, contraceptive, and social life events. Contraception 1990; 41: 475-83.

  23. Lidegaard Ø, Olsen O, Kristensen TS. Aetiology and prevention of diseases. Theory and practice. [da]. Nord Med 1990; 105: 87-90.

  24. Lidegaard Ø, Dirksen A, McNair P. Medical informatics. [da]. Ugeskr Laeger 1990; 152: 1149-51.

  25. Lidegaard Ø, Meinert L, Weber T. Birth technologies at Danish maternity units. [da] Ugeskr Laeger 1990; 152: 3702-5.

  26. Lidegaard Ø, Weber T. Gynaecology og obstetrics in Denmark year 2000. [da]. Ugeskr Laeger 1990: 152: 3107-13.

  27. Helm P, Lidegaard Ø. The relationship between menarche and sexual, contraceptive, and reproductive life events. Scand J Prim Health Care 1990; 8: 59-63.

  28. Lidegaard Ø. Medical informatics in Denmark/Europe. [da]. Ugeskr Læger 1991; 153: 593-4.

  29. Jensen LM, Jørgensen JS, Lidegaard Ø, Brinsden PR, Weber T. Spontaneous selective abortion of twin A with Down's syndrome followed by delivery of a normal twin B 14 weeks later. Eur J Obstet Gynecol Reprod Biol 1991: 42: 159-61.

  30. Lidegaard Ø, Meinert L, Weber T. Description, evaluation and clinical decision making according to different fetal heart rate patterns. Inter-observer and regional variability. Acta Obstet Gynecol Scand 1992; 71: 48-53. Pdf

  31. Lidegaard Ø, Jensen LM, Weber T. Description, evaluation and clinical decision making according to different fetal heart rate patterns. Inter-observer and regional variability. [Da] Ugeskr Laeger 1992; 71: 48-53.

  32. Madsen EM, Lidegaard Ø, Tabor A. Oophorectomy per occasionem and ovarian cancer. A survey. [da]. Ugeskr Laeger 1992.

  33. Lidegaard Ø. Oral contraception and risk of cerebral thromboembolic attacks: results of a case-control study. BMJ 1993; 306: 956-63. Pdf

  34. Lidegaard Ø. Postgraduate education of physicians. [Da] Ugeskr Laeger 1993; 155: 2485-9.

  35. Lidegaard Ø. Oral contraceptives and thrombosis. An update. [Da] Månedsskr Praktisk Laegegerning 1993; 71: 801-5.

  36. Lidegaard Ø. Oral contraceptives and cerebral thrombosis. [Da] Ugeskr Laeger 1993; 155: 3538-45. (Danish version of ref. 40).

  37. Lidegaard Ø. OC-use in Denmark 1980-1990 and smoking habits among fertile women in 1990. [Da] Ugeskr Laeger 1993; 3550-8.

  38. Lidegaard Ø. Research among Danish Doctors. [Da] Ugeskr Laeger 1993; 155: 3970-72.

  39. Lidegaard Ø. The influence from the technological development on the future structure of the Danish Health Care Sector. [Da] Ugeskr Laeger 1993; 155: 3622-3.

  40. Banfield P, Lidegaard Ø, Lange AK, Weber T. The obscare textbook. Concepts and principles of quality assurance and clinical audit in maternity services. WHO, October 1993.

  41. Madsen EM, Lidegaard Ø, Tabor A. Oophorectomy in the prevention of ovarian cancer. Acta Obstet Gynecol Scand 1993; 72: 599-600. Pdf

  42. Lidegaard Ø, Meinert L, Weber T. Technology use, Caesarean sections, and perinatal mortality at Danish Maternity Wards. Acta Obstet Gynecol Scand 1994; 73: 240-5. Pdf

  43. Lidegaard Ø. Cervical incompetence and cerclage in Denmark 1980-1990. An epidemiological survey. Acta Obstet Gynecol Scand 1994; 73: 35-8 . Pdf

  44. Lidegaard Ø, Krumpaszky HG, Roos JL, Johansen KS. European consensus conference on quality development indicators for perinatal care. Tübingen October 1993. WHO, Copenhagen November 1994.

  45. Lidegaard Ø. Cervical incompetence and cerclage in Denmark 1980-1990. (Da) Ugeskr Læger 1994; 156: 7200-2. Parallel publication to ref 53.

  46. Lidegaard Ø. Oral contraceptives and cerebral thrombosis. An epidemiological approach. In Creatsas G, Serfaty D, Skouby S (Ed): Proceedings of the 3rd Congress of the European Society of Contraception. Athens 1994, p 81-5.

  47. Lidegaard Ø. Oral contraceptives, pregnancy and the risk of cerebral thromboembolism: the influence of diabetes, hypertension, migraine and previous thrombotic disease. Br J Obstet Gynceol. 1995; 102: 153-9.

  48. Lidegaard Ø. Decline in cerebral thromboembolism among young women after introduction of low-dose oral contraceptives: An incidence study for the period 1980-1993. Contraception 1995; 52: 85-92. Pdf.

  49. Lidegaard Ø. Oral contraceptives and smoking, migraine, hypertension, diabetes, and previous thrombosis. A risk assessment with special reference to cerebral thromboembolism. Fertility Control Reviews 1995; 4: 14-5.

  50. Mosgaard B, Lidegaard Ø, Andersen AN. Use of fertility drugs in Denmark 1973-1993. Acta Obstet Gynaecol Scand 1995; 74: 614-8. Pdf

  51. Lidegaard Ø, Milsom I. The pill. The controversy continues. Acta Obstet Gynecol Scand 1996; 75: 93-7. Pdf

  52. Lidegaard Ø, Milsom I. Oral contraceptives and thrombotic diseases: Impact of new epidemiological studies. Contraception 1996; 53: 135-9.

  53. Lidegaard Ø. Pill scare in profile. Global perspectives. Gynaecology Forum 1996; 1: 18-9.

  54. Lidegaard Ø. Decline in cerebral tromboembolism among young women after the introduction of low-dose oral contraceptives. Ugeskr Laeger 1996; 158: 5933-9. (parallelpubl. to ref. 59)

  55. Lidegaard Ø. Oral contraceptives and risk of arterial vascular disease. Gynecol Endocrinol 1996; 10 Suppl 2, 9-12.

  56. Lidegaard Ø. Oral contraceptives and venous thromboembolism: an epidemiological review. Eur J Contracep Reproduc Health Care 1996; 1: 13-20.

  57. Lidegaard Ø, Tabor A, Weber T, Loft A, Roos JL, Thomsen SG. Written patient information.. [da] Ugeskr Laeger 1996; 158: 2578-82.

  58. Lidegaard Ø. Oral contraceptives and migraine. In Hannaford PC, Webb AMC (Ed). Evidence-guided prescribing of the pill. Parthenon Publishing Group, London 1996; 299-306.

  59. Lidegaard Ø, Milsom I. Oral contraceptives and thrombotic diseases: Impact of new epidemiological studies. Letter. Contraception 1996; 54: 195-8.

  60. Cretsas G, Pitsavos C, Amy JJ et al. A multicenter European survey of the attitudes to contraception in women at high risk or with established cardiocascular disease. Eur J Contracept Reprod Health Care 1996; 1: 267-73.

  61. Lidegaard Ø. Oral contraceptives and stroke. Issues and recommendations. CNS Drugs 1997; 7: 1-5.

  62. Lidegaard Ø. Oral contraceptives and cerebral thromboembolism. Acta Obstet Gynecol Scand 1997; Suppl. 164: 76: 66-68.

  63. Lidegaard Ø. The influence of thrombotic risk factors when oral contraceptives are prescribed. Acta Obstet Gynaecol Scand 1997; 76: 252-60. Pdf

  64. Lidegaard Ø. Tromboembolic complications by use of oral contraceptives. Editorial. Ugeskr Laeger 1997; 159; 1908-9.

  65. Lidegaard Ø, Milsom I. Oral contraceptives and venous thromboembolism. Lancet 1997, letter; 349: 1621.

  66. Lidegaard Ø. Oral contraceptives and stroke: Issues and recommendations. J Paediatrica, Obstetrics & Gynaecology 1997; 23: 5-7. (Parallel publ. to 72)

  67. Lidegaard Ø. Oral contraceptives and stroke: Issues and recommendations. J Practical Patient Care 1997; 26: 43-6. (Parallel publication to 72)

  68. Mosgaard BJ, Lidegaard Ø, Andersen AN. The impact of parity, infertility and treatment with fertility drugs on the risk of ovarian cancer. A survey. Acta Obstet Gynecol Scand 1997; 76: 89-95. Pdf

  69. Mosgaard BJ, Lidegaard Ø, Kjær SK, Schou G, Andersen AN. Infertility, fertility drugs and invasive ovarian cancer: A case-control study. Fertil Steril 1997; 67: 1005-12. Pdf.

  70. Loft A, Lidegaard Ø, Tabor A. Incidence of ovarian cancer after hysterectomy - a nationwide controlled follow up. Br J Obstet Gynecol 1997; 104: 1296-1301. Pdf

  71. Pedersen AT, Lidegaard Ø, Kreiner S, Ottesen B. Hormone replacement therapy and risk of non-fatal stroke. Lancet 1997; 350: 1277-83. Pdf.

  72. Milsom I, Odlind V, Hedberg C, Lidegaard Ø. Concern about increase in abortion rate [Swedish]. Läkartidningen 1997; 50: 4731-6.

  73. Lidegaard Ø, Kreiner S. Cerebral thrombosis and oral contraceptives. A case-control study. Contraception 1998; 57: 303-14. Pdf.

  74. Lidegaard Ø, Edström B, Kreiner S. Oral contraceptives and venous thromboembolism. A case-control study. Contraception 1998; 57: 291-301. Pdf.

  75. Lidegaard Ø. Thrombotic diseases in young women and the influence of oral contraceptives. Am J Obstet Gynecol 1998; 179: S62-7. Pdf.

  76. Lidegaard Ø, Mikkelsen AL, Meldgaard M, Brøndum-Nielsen K, Lindenberg S. Severe male infertility. Impact of genetic factors on diagnosis and counselling. Acta Obstet Gynecol Scand 1998; 77: 799-803. Pdf

  77. Lidegaard Ø. Oral contraceptives and thrombosis [da]. Nordisk Medicin 1998; 113: 187-90.

  78. Bertelsen CA, Andreasson B, Lidegaard Ø. Oestrogen substitution to women treated for breast cancer [da]. Ugeskr Laeger 1998; 160: 6954-7.

  79. Mosgaard BJ, Lidegaard Ø, Kjær SK, Schou G, Andersen AN. Ovarian stimulation and borderline ovarian tumors. A case-control study. Fertil Steril 1998; 70: 1049-55. Pdf.

  80. Lidegaard Ø, Larsen JF. Early medical abortion. An update [da]. Ugeskr Laeger 1999, 161: 3275-7.

  81. Lidegaard Ø, Larsen JF, Blaabjerg J, Larsen E. The first 100 early medicical abortions. [da] Ugeskr Laeger 1999; 161: 3278-81.

  82. Lidegaard Ø, Bygdeman M, Milsom I, Nesheim B-I, Skjeldestad FE, Toivonen J. Oral contraceptives and thrombosis. From risk estimates to health impact. Acta Obstet Gynecol Scand 1999; 78: 142-9. Pdf

  83. Lidegaard Ø. Smoking and use of oral contraceptives. Impact on thrombotic diseases. Am J Obstet Gynecol 1999; 180: S357-63. Pdf.

  84. Lidegaard Ø. Oral contraceptives and myocardial infarction: reassuring new findings. Commentary. BMJ 1999; 518: 1583-4. Pdf.

  85. Parslov M, Lidegaard Ø, Klintorp S, Pedersen B, Jønsson L, Eriksen PS, Ottesen B. Risk factors among young women with endometrial cancer. A Danish case-control study. Am J Obstet Gynecol 2000; 182: 23-9. Pdf.

  86. Godsland IF, Winkler U, Lidegaard Ø, Crook D. Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms. Drug 2000: 60: 721-869.

  87. Lidegaard Ø. The risk of ischaemic stroke is increased in current users of oral contraceptives. Commentary. Evidence-based Obstet Gynecol 2000; 2: 74.

  88. Poulsen EF, Lidegaard Ø, Schiødt AV. Contraception in Denmark year 2000. [Danish]. Ugeskr Laeger 2000; 163; 4533-6.

  89. Lidegaard Ø, Schiødt AV, Poulsen EF. Oral contraceptives. General considerations. [Danish]. Ugeskr Laeger 2001; 163: 4544-6.pdf

  90. Lidegaard Ø, Poulsen EF, Schiødt AV. Oral contraceptives for women with special risk factors. [Danish]. Ugeskr Laeger 2001; 163: 4546-8.pdf

  91. Lidegaard Ø, Schiødt AV, Poulsen EF. Oral contraceptives and thrombosis. [Danish]. Ugeskr Laeger 2001; 163: 4549-53.pdf

  92. Lidegaard Ø. Spontaneous abortion. Editorial. [Danish] Ugeskr Laeger 2001; 163: 2121.

  93. Lidegaard Ø, Kreiner S. Oral contraceptives and cerebral thrombosis. A five-year National case-control study. Contraception 2002; 65: 197-205. Pdf.

  94. Lidegaard Ø, Edström B, Kreiner S. Oral contraceptievs and venous thromboembolism. A five-year national case-control study. Contraception 2002; 65: 187-196. Pdf.

  95. Lidegaard Ø. Emergency contraception. [Da]. Nødprævention i håndkøb. Editorial. Ugeskr Laeger 2002; 164: 4999.

  96. Lidegaard Ø, Hammerum MS. National Registry of Patients as a tool in continuous production and quality control. [Da]. Ugeskr Laeger 2002; 164: 4420-3.

  97. Lidegaard Ø. Emergency contraception over the counter. Editorial. [Da] Ugeskr Laeger 2002; 164: 4999.

  98. Grønlund L, Grønlund A-L, Clevin L, Andersen B, Palmgren N, Lidegaard Ø. Spontaneous abortion. Expectant management, medical treatment or surgical evacuation. Acta Obstetricia et Gynecologica 2002: 81: 781-2. Pdf.

  99. Grønlund A-L, Grønlund L, Clevin L, Andersen B, Palmgren N, Lidegaard Ø. Management of missed abortion. Comparison of medical treatment with either mifepristone+misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen County, Denmark. Acta Obstetricia et Gynecologica 2002: 81; 1060-65. Pdf.

  100. Hammerum MS, Lidegaard Ø. Induced abortion at Gynaecological departments in Denmark 1999-2003. Www.tigrab.dk. 2002-2006.

  101. Hammerum MS, Lidegaard Ø. Spontaneous and missed abortions at Gynaecological Departments in Denmark 1999-2003.  Www.tigrab.dk. 2001-2006

  102. Lidegaard Ø. Absolute and attributable risk of venous thromboembolism in women on cyproterone acetate. J Obstet Gynaecol Canada 2003; 25: 575-7. Pdf.

  103. Lidegaard Ø, Utzon J, Nørgaard L, Møller TW. Clinical quality databases in Denmark year 2003. [Da]. Ugeskr Læger 2003; 165: 3737-40. Pdf.

  104. Lidegaard Ø. Hormonel patch contraception. [Da]. Ugeskr Laeger 2004; 166: 3591. Pdf

  105. Lidegaard Ø, Hammerum MS. Hysterectomies in Denmark 1998-2003. http://Www.dsog.dk. DSOG 2002-2004.

  106. Lidegaard Ø, Hammerum MS. Endometrial ablations at Gynaecological Departments in Denmark 1996-2003. [Da]. Www.dsog.dk/kvalitet. DSOG 2002-2004.

  107. Lidegaard Ø, Hammerum MS. Ectopic pregnancies in Denmark 1995-2003. http://Www.tigrab.dk. 1998-2006.

  108. Helm P, Lidegaard Ø. Sterilisations in Denmark 1996-2003. National follow-up. http://Www.dsog.dk. DSOG 2004.

  109. Lidegaard Ø, Jaszczak P. Quantification of ressources allocated to postgraduate education of doctors.  [Da] (Kvantificering af resurser allokeret til lægelig videreuddannelse). Ugeskr Laeger 2004; 166: 2037-40. Pdf

  110. Lidegaard Ø, Kroman N. The epidemiology of breast cancer. Eur Clin Obstet Gynaecol 2005; 1: 24-8. Pdf.

  111. Lidegaard Ø, Pinborg A, Andersen AN. Imprinting diseases and IVF. Danish National IVF cohort study. Hum Reprod 2005; 20: 950-4. Pdf.

  112. Lidegaard Ø, Poulsen EF. Contraception [Da]. In Ottesen B, Mogensen O, Forman A (Ed): Gynaecology [Da]. Munksgaard, Copenhagen 2005; 3: 106-24.

  113. Secher LL, Klysner AH, Lidegaard Ø. Treatment of ectopic pregnancies in Denmark. [Da]. Ugeskr Laeger 2005; 167: 2048-50. Pdf

  114. Pinborg A, Lidegaard Ø, Freiesleben NLC, Andersen AN. Consequences of vanishing twins in IVF/ICSI pregnancies. Hum Reprod 2005; 20: 2821-9. Pdf

  115. Kroman N, Lidegaard Ø, Kvistgaard ME. Breast cancer - an acquired disease? [Da] Mammacancer - en livsstilssygdom?. Ugeskr Laeger 2005; 167: 4636-41.Pdf

  116. Lidegaard Ø, Pinborg A, Andersen AN. Imprinting disorders after assisted reproductive technologies. Curr Opin Obstet Gynecol 2006; 18: 293-6. Pdf.

  117. Pinborg A, Lidegaard Ø, Andersen AN. The vanishing twin - a major determinant of infant outcome in IVF singletons. Br J Hosp Med 2006; 67: 417-20.

  118. Lidegaard Ø. Gynaecological epidemiology [Danish]. Ugeskr Laeger 2006; 168; 3806-8. pdf

  119. Lidegaard Ø, Hansen NF. De novo development of dyspnoea in a young healthy woman with fatal outcome. [Danish]. Ugeskr Laeger 2007; 169: 2032-3. pdf.

  120. Lynge, E, Rostgaard K, Kroman N, Lidegaard Ø, Kvistgaard ME. Descriptive epidemiology: Trend in incidence of breast cancer by time, geographical and social differences, risk factors, etc. [Danish]. Ugeskr Laeger 2007: 169: 2965-7. Pdf.

  121. Pinborg A, Lidegaard Ø, Freiesleben NLC, Andersen AN. Vanishing twins: a predictor of small-for-gestational age in IVF singletons. Hum Reprod 2007; 22: 2707-14. Pdf

  122. Løkkegaard E, Lidegaard Ø, Møller LN, Agger C, Andreasen AH, Jørgensen T. Hormone replacement therapy in Denmark 1995-2004. Acta Obstet Gynaecol 2007; 86: 1342-51.pdf

  123. Lidegaard Ø, Svendsen AL. Sexual habits before multiple sclerosis. A National case-control study. Multiple Sclerosis 2008; 14: 73-80. pdf

  124. Lidegaard Ø. Oral contraceptives: 40 years after release. Acta Obstetricia Gynecologica 2008; 87: 4-5. pdf

  125. Lidegaard Ø, Lidegaard M. Global climate: The sick patient [Danish] Klodens klima: den syge patient. Ugeskr Laeger 2008; 170: 2663-6. Pdf

  126. Lidegaard M, Lidegaard Ø. Global climate: The curative therapy. [Danish] Klodens klima: Den kurative terapi. Ugeskr Laeger 2008; 170: 2714-7. Pdf. 

  127. Løkkegaard E, Andreasen AH, Jacobsen RK, Nielsen LH, Agger C, Lidegaard Ø. Hormone therapy and risk of myocardial infarction. A National registry study. Eur Heart J 2008; 29: 2660-8. Pdf

  128. Lidegaard Ø. National Registry of Patients - again. [Danish] Landspatientregisteret - igen. Editorial. Ugeskr Laeger 2009: 171: 397. Pdf.

  129. Petri AL, Høgdall C, Lidegaard Ø. Diagnosis of primary ovarian cancer in Denmark [Danish]. Diagnoseregistrering af primær ovariecancer i Danmark. Ugeskr Laeger 2009; 171: 408-11. Pdf.

  130. Lidegaard Ø, Vestergaard CHF, Hammerum MS. Quality assessment based on registry data [Danish]. Kvalitetsmonitorering ud fra data i Landspatientregisteret. Ugeskr Laeger 2009; 171: 412-5. Pdf.

  131. Forstholm MM, Lidegaard Ø. Maternal request in Denmark 2001-2006. [Danish]. Ugeskr Laeger 2009; 171: 497-502. Pdf

  132. Vestergaard CHF, Lidegaard Ø, Tabor A. Invasive prenatal diagnostic practice in Denmark 1996-2006. Acta Obstet Gynecol Scand 2009; 88: 362-5. Pdf

  133. Lidegaard Ø. Sea level and CO2. Lessons from the past. Climate Change: Global Risks, Challenges and Decisions 2009. doi:10.1088/1755-1307/6/7/072038. Pdf. Climate conference poster: pdf

  134. Tabor A, Vestergaard CHF, Lidegaard Ø. Fetal loss rate after chorionic villus sampling and amniocentesis. An 11-year national registry study. Ultrasound in Obstetrics and Gynecology 2009; 34: 19-24. pdf

  135. Lidegaard Ø, Løkkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism. A National follow-up study. BMJ 2009; 339: b2890 pdf

  136. Mørch LS, Løkkegaard E, Andreasen AH, Kjær SK, Lidegaard Ø. Hormone therapy and ovarian cancer. A National Cohort study. JAMA 2009; 302: 298-305. pdf

  137. Lidegaard Ø, Ricketts MN. Climate change and health care. Seminar of the World Medical Association. Danish Medical Association, Copenhagen 2009. pdf

  138. Lidegaard Ø. Lifestyle and climate change [Danish]. Ugeskr Laeger 2009; 171: 3194-7. pdf

  139. Færgeman O, Lidegaard Ø. Climate and health [Danish]. Ugeskr Laeger 2009; 171: 3163. pdf

  140. Lidegaard Ø. Climate and health. Acta Obstet Gynecol 2009; 88: 1305-6. pdf

  141. Moeller LBK, Moeller C, Thomsen SG, Andersen LF, Lundvall L, Lidegaard Ø, Kjer JJ, Ingemanssen JL, Zobbe V, Floridon C, Petersen J, Ottesen B. Success and spontaneous pregnancy rates following systemic methotrexate versus laparoscopic surgery for tubal pregnancies: a randomized trial. Acta Obstet Gynecol Scand. 2009; 88:1331-7. pdf

  142. Lidegaard Ø, Vestergaard CHF, Krogh LN, Tabor A. Halving the invasive prenatal diagnostic testing rate simultaneously with increasing the detection rate of chromosomal malformations. A National survey 2000-2006. Acta Obstet Gynecol Scand. Submitted.

  143. Helm P, Lidegaard Ø, Vestergaard CHF. Unintended pregnancies following female sterilisation. A National follow-up of 58,240 unselected sterilisations. Eur J Contraception Reproductive Health 2009; submitted.

  144. Forstholm MM, Langhoff-Roos J, Lidegaard Ø. Maternal request among primiparous. A case-control study. [Danish]. Ugeskr Laeger 2009; submitted.

  145. Nielsen HS, Lund M, Mortensen LH, Andersen A-MN, Lidegaard Ø, Christiansen OB. Frequency and impact of obstetric complications prior and subsequent to unexplained secondary recurrent miscarriage. Hum Reprod 2009; submitted.

3: Ongoing studies

  1. Lidegaard Ø, Vestergaard CHF, Hammerum M, Dziegiel MH, Poulsen D, Johansson PI, Titlestad K, Johnsen SP, Svendsen AL. Severe haemorrhage after medically and surgically induced abortion.

  2. Lidegaard Ø, Løkkegaard E, Møller LN, Agger C, Andreasen AH. A National register study on breast cancer risk with hormone therapy in Danish women. Part 1. Main results on hormone regimens in postmenopausal women.

  3. Lidegaard Ø, Løkkegaard E, Møller LN, Agger C, Andreasen AH. Hormone therapy and breast cancer. A National follow-up of Danish women. Part II. Route of administration, estrogen dose and progestagen type.

  4. Mørch LS, Lidegaard Ø, Andreasen AH, Løkkegaard E. Risk factors for hormone use in Denmark.

  5. Dideriksen KL, Lykke JA, Langhoff-Roos J, Lidegaard Ø. The predictive value of bleeding in early pregnancy for postnatal morbidity in the offspring. A National follow-up study.

  6. Lykke JA, Lidegaard Ø, Dideriksen KL, Langhoff-Roos J. First trimester bleeding and subsequent obstetrical complications. A National case-control study.

  7. Lidegaard Ø, Løkkegaard E. Danish Sex Hormone Register Study. A Danish cohort of 1.8 mio women followed from January 1 1995 through 2004, stratified according to exposure to oral contraceptives and hormone replacement therapy and assessing all cardiovascular and cancer end points. Expected finished by end of 2010.

  8. Lidegaard Ø, Vestergaard CHF. Quality assessment at Danish Gynaecological departments by use of data in the National Register of Patients. Follow up on primary report (ref. 11). Annual follow-up until 2008. See www.tigrab.dk